NCT01172691View on ClinicalTrials.gov

Trial of Inhaled Nitric Oxide (iNO) on Ischemia / Reperfusion Injury During Orthotopic Liver Transplantation With Marginal Grafts

PHASE2UnknownINTERVENTIONAL
Enrollment

2

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Liver Transplant
Interventions
PROCEDURE

Inhaled Nitric Oxide (iNO)

iNO or placebo will be administered at 40 ppm during the procedure starting when the Warm Ischemia Time begins - liver from ice. Stop when patient transported to ICU

Trial Locations (1)

75246

Baylor Univsersity Medical Center, Dallas

Sponsors

Collaborators (1)

Mallinckrodt
All Listed Sponsors
collaborator

Mallinckrodt

INDUSTRY

lead

Baylor Research Institute

OTHER